04 · Properties of the Cosmos宇宙的属性

Longevity / Immortality长生不老

Level · Entropy层级 · 熵

"Aging is not a season but a debt; pay the debt and the season disappears.""衰老不是一个季节，而是一笔欠账；偿清欠账，季节本身便消失。"

Plane位面

Order秩序

Value价值观

Better Living改良生活

Cosmic name其名

Eternal Operation无量运行

The frontier前沿概述

Entropy is the universal tax — disorder grows in any closed system. Life persists by running a local counter-current, importing energy and exporting heat. Aging is what happens when that counter-current starts to leak: information loss in cells, misfolded proteins, exhausted stem-cell niches. The longevity frontier reframes aging from inevitability to engineering problem. The bet: nine identifiable Hallmarks of Aging, each separately targetable, each yielding to the right molecule, gene edit or reprogramming protocol.熵，是宇宙的赋税：在任何封闭系统中，无序持续累积。生命的存续，依赖一股局部的反向暗流——输入能量、输出热量。衰老，发生在这股暗流开始渗漏的时候：细胞中的信息流失、蛋白错折、干细胞龛位耗竭。长寿前沿，把衰老从命运重写为工程问题。其赌注是：九项可识别的衰老特征，每一项都能被单独锁定——交给恰当的分子、基因编辑或重编程方案。

Historical evolution历史演化

1961
Hayflick limit海弗里克极限
Cells in culture only divide a finite number of times — aging has a clock.培养中的细胞只能分裂有限次——衰老有钟。
1990s
Telomere biology端粒生物学
Telomerase and telomere length become the first molecular handles on senescence.端粒酶与端粒长度成为衰老的首批分子把手。
2006
Yamanaka factors山中因子
Four genes can reset an adult cell to an embryonic state — aging is, in principle, reversible.四个基因可把成体细胞重置为胚胎态——衰老在原理上可逆。
2013
Nine Hallmarks衰老九大特征
López-Otín et al. give the field a structured target list.López-Otín 等给出领域的结构化靶标清单。
2020s
Altos, Retro, CalicoAltos、Retro、Calico
Billion-dollar private labs put cellular rejuvenation on industrial footing.十亿美元级私营实验室把细胞回春放上工业化轨道。

State of the art今日状态

Senolytics clear zombie cells; partial reprogramming via cyclic Yamanaka expression rejuvenates tissue in mice; GLP-1 drugs unexpectedly extend healthspan markers. Clinical trials of rapamycin, metformin and NAD+ precursors are ongoing. No proven human lifespan extension yet — but the curve of biological-age biomarkers is now bendable in lab animals, and the first human longevity drugs are in trials.Senolytic 清除“僵尸细胞”；循环表达山中因子在小鼠身上重塑组织；GLP-1 药物意外地延长健康跨度的多项指标。雷帕霉素、二甲双胍、NAD+ 前体的临床试验正在进行。人类寿命的实证延长尚未达成——但在实验动物中，生物年龄标志物的曲线已经可弯，第一批针对衰老本身的人体药物进入临床。

Where it goes next未来走向

→
First FDA-approved longevity indication — likely senolytic for an aging-related disease — within the decade.首个 FDA 批准的“抗衰老”适应症——很可能是某种 Senolytic——会在十年内出现。
→
Partial reprogramming in humans, age-reversal on the order of years.针对人体的部分重编程，把生物年龄回拨数年。
→
Cryonics or whole-brain emulation as the fallback when biology runs out of room.当生物路径走到尽头，冷冻保存或全脑仿真作为退路。

Applications today现今应用

Healthspan extension — more good years before decline.健康跨度延长——衰退前的“好年头”更长。
Regenerative medicine — printable organs, replenished stem-cell niches.再生医学——可打印器官、可补给的干细胞龛位。
Demographic and pension policy redesign.人口结构与养老金政策的重新设计。